Hypnofast 7.5 mg (Tablet)
Medicine Details
Category | Details |
---|---|
Generic | Midazolam |
Company | Incepta pharmaceuticals ltd |
Also available as |
Indications
- Short-term treatment of insomnia
- Sedation in premedication before surgical or diagnostic procedures
Description
Sleep-inducing agent characterized by rapid onset and short duration of action, exerts anxiolytic, anticonvulsant and muscle-relaxant effect
Pharmacology
- Actions mediated through inhibitory neurotransmitter gamma-aminobutyric acid (GABA)
- Increases activity of GABA producing sedating effect, relaxing skeletal muscles, inducing sleep, anesthesia, and amnesia
- Binds to benzodiazepine site on GABA-A receptors, potentiating effects of GABA
Dosage & Administration
- Oral dosage for adults: 7.5-15 mg daily
- Oral dosage in elderly and debilitated patients: The recommended dose is 7.5 mg
- Oral dosage in premedication: 15 mg should be given 30-60 minutes before the procedure
- Intravenous administration for endoscopic or cardiovascular procedures: In healthy adults, the initial dose is approximately 2.5 mg
- Intravenous administration for induction of anesthesia: The dose is 10-15 mg
- Intramuscular administration for adult: 0.07-0.1 mg/kg body weight
- Intramuscular administration for children: 0.15-0.20 mg/kg
- Intramuscular administration for elderly and debilitated patients: 0.025-0.05 mg/kg
- Rectal administration in children for preoperative sedation: Rectal administration of the ampoule solution (0.35-0.45 mg/kg) 20-30 min before induction of general anesthesia
Interaction
Enhances the central sedative effect of various drugs including neuroleptics, tranquillizers, antidepressants, sleep-inducing drugs, analgesics, anesthetics, antipsychotics, anxiolytics, antiepileptic drugs and sedative antihistamines
Contraindications
Must not be given to patients with severe respiratory insufficiency, severe hepatic insufficiency, myasthenia gravis, sleep apnea syndrome and with known hypersensitivity to benzodiazepines or to any component of the product
Side Effects
- At the start of therapy: drowsiness during daytime, confusion, fatigue, headache and muscle weakness
- Following parenteral administration: fluctuations in vital signs including respiratory depression, apnea, variations in blood pressure and pulse rate
Pregnancy & Lactation
Should be avoided during pregnancy unless there is no safer alternative. Should not be administered to breastfeeding mothers due to passage into breast milk
Precautions & Warnings
IV administration should be very slow
Overdose Effects
Extreme overdosage may lead to coma, areflexia, cardiorespiratory depression and apnea. The effects of overdosage can be controlled with benzodiazepine antagonist flumazenil
Therapeutic Class
- Benzodiazepine hypnotics
- Benzodiazepine sedatives
Storage Conditions
Protect from light and moisture, store in cool and dry place, keep out of the reach of children